About Jennifer

Jennifer brings 18 years of managed care experience with both PBM and large health plans to the Precision team. Prior to coming to Precision, Jennifer most recently was Director of Utilization and Clinical Management for Oncology at CVS Health/Aetna, where she was responsible for the development and maintenance of clinical content for oncology utilization management programs and services. Jennifer is a Board-Certified Oncology Pharmacist with strong clinical expertise in both pharmacy and medical covered oncology drugs. She was recently instrumental in the expansion of Aetna’s site of care program into the immuno-oncology setting. During her time at Aetna, she served as the pharmacy representative to the gene, cellular and innovative therapies team which worked to develop comprehensive gene therapy management programs. Prior experience includes specialty pipeline, specialty trend management, evaluating drugs for P&T Committee review, and formulary management for commercial, Medicare Part D, and exchange lines of business. She was also a contractor for CMS on the Medicare Part D Formulary & Benefit Review Task Order where she was responsible for ensuring plan sponsor’s formularies and criteria were clinically appropriate and compliant with all CMS formulary requirements.

Since joining Precision, Jennifer has focused on supporting market access in many therapeutic areas including oncology, biosimilars, rare disease, specialty, and gene therapies.

EDUCATION:
PharmD, Creighton University

MEMBERSHIPS:
Academy of Managed Care Pharmacy (AMCP)
Hematology/Oncology Pharmacy Association (HOPA)
Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) G-CSFs Research Team (past member)